Avacta reports positive preclinical results for dual-payload cancer candidate AVA6207
Life sciences company Avacta Therapeutics (AIM:AVCT) on Thursday reported new preclinical data showi
Life sciences company Avacta Therapeutics (AIM:AVCT) on Thursday reported new preclinical data showi